Arthrex Spine Compression FT Screw
ARTHREX, INC. · Decision date Sep 24, 2026
What did the FDA decide?
FDA's 510(k) database records K262618 for the Arthrex Spine Compression FT Screw, submitted by Arthrex, Inc. of Naples, Florida, and received on 07/28/2026. The device is listed under classification product code MRW, with HWC as a subsequent product code, and the review panel is recorded as Orthopedic. The record describes the submission type as Traditional, with no third-party review, no combination product status and no authorized predetermined change control plan.
FDA recorded a decision of Substantially Equivalent (SESE) on 09/24/2026, meaning the submission was cleared as a 510(k) rather than approved through the PMA pathway. The record does not identify a predicate device, summarize the technological comparison, or describe the specific screw components or indications for use; the specialty field is listed as Unknown. The public page was last updated 09/28/2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262618
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ARTHREX, INC.
- Product code
- MRW
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Facet Screw Spinal Device.
- Applicant
- Arthrex, Inc.
- Product code
- MRW
- FDA device class
- U
FDA decision timeline
K262618 received
Application receipt date recorded by FDA.
K262618 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Arthrex, Inc.
- Headquarters
- Not reported
- Brand website
- arthrex.com
- FDA applicant address
- Naples, FL
Sources and methodology
- Original FDA record: K262618
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records